Literature DB >> 31573829

Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy.

Jon M Richards1, Trever B Burgon2, Diana Tamondong-Lachica2, Jacob D Bitran1, Wilfredo L Liangco2, David R Paculdo2, John W Peabody2,3,4.   

Abstract

PURPOSE: Addressing unwarranted clinical variation in oncology is a high priority for health systems that aspire to ensure consistent levels of high-quality and cost-effective care. Efforts to improve clinical practice and standardize care have proven challenging. Advocate Physician Partners undertook a patient simulation-based practice measurement and feedback project that was focused on breast and lung cancer to engage oncologists in the care standardization process.
METHODS: One hundred three medical oncologists cared for online simulated patients using the Clinical Performance and Value platform, receiving feedback on how their care decisions compared with evidence-based guidelines and their peers. We repeated this process every 4 months over six rounds, measuring changes in quality-of-care scores. We then compared simulated patient results with available patient-level claims data.
RESULTS: Over the course of the project, overall quality-of-care scores improved 11.9% (P < .001). Diagnostic accuracy increased 6.7% (P < .001) and correlated with improved treatment scores, including a nearly 10-percentage point increase in evidence-based chemotherapy regimens (P = .009) and a 56% increase in addressing palliative needs for patients with late-stage disease (P < .001). Unnecessary test ordering declined 25% (P < .001). We compared these results with available patient data and observed concordance with the metastatic imaging workup order rate for early-stage breast cancer. As unnecessary workups declined in the simulations and became more closely aligned with evidence-based guidelines, we saw similar rates of decline in the patient-level data.
CONCLUSION: This study demonstrates that an oncology care standardization system that combines simulated patients with serial feedback increases evidence-based and cost-effective clinical decisions in patient simulations and patient-level data.

Entities:  

Year:  2019        PMID: 31573829     DOI: 10.1200/JOP.18.00754

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  3 in total

1.  Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.

Authors:  Sarah P Huepenbecker; Charlotte C Sun; Shuangshuang Fu; Hui Zhao; Kristin Primm; Sharon H Giordano; Larissa A Meyer
Journal:  Cancer       Date:  2021-08-04       Impact factor: 6.860

2.  Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions.

Authors:  Mohamed Gad; Ahmed Salem; Wija Oortwijn; Ruaraidh Hill; Brian Godman
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

3.  Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial.

Authors:  Trever Burgon; Linda Casebeer; Holly Aasen; Czarlota Valdenor; Diana Tamondong-Lachica; Enrico de Belen; David Paculdo; John Peabody
Journal:  J Med Internet Res       Date:  2021-12-23       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.